Abstract
The reactions of glycine hydroxamic and DL-alanine hydroxamic acids with triacetonamine are chemoselective and afford 1-hydroxy-7,7,9,9-tetramethyl-1,4,8-triazaspiro[4.5]decan-2-one (3) and (±)-1-hydroxy-3,7,7,9,9-pentamethyl-1,4,8-triazaspiro[4.5]decan-2-one (4), respectively. The X-ray diffraction study showed that compound 3 crystallizes as a solvate with MeCN (1: 1). As shown by ESR measurements, spiro hydroxamic acids 3 and 4 are NO donors in in vitro biological systems. The NO-donor activity of compounds 3 and 4 was found to be substantially higher in the presence of DMSO. Homologue 4 is a stronger NO donor than 3. Compound 4 also exhibits high antimetastatic activity (81%) on the B16-melanoma model.
Similar content being viewed by others
References
C. J. Marmion, D. Griffith, K. B. Nolan, Eur. J. Inorg. Chem., 2004, 3003; D. Griffith, K. Krot, J. Comiskey, K. B. Nolan, C. J. Marmion, Dalton Trans., 2008, 1, 137.
R. Hoekstra, F. A. L. M. Eskens, J. Verweij, Oncologist, 2001, 6, 415; M. Hidalgo, S. G. Eckhardt, J. Natl. Cancer Inst., 2001, 93, 178; J. B. Nielands, Science, 1967, 156, 1443.
M. Whittaker, C. D. Floyd, P. Brown, A. J. H. Gearing, Chem. Rev., 1999, 99, 2735.
T. A. Miller, D. J. Witter, S. Belvedere, J. Med. Chem., 2003, 46, 5097.
(a) L. N. Koikov, N. V. Alexeeva, E. A. Lisitza, E. S. Krichevsky, N. B. Grigoryev, A. V. Danilov, I. S. Severina, N. V. Pyatakova, V. G. Granik, Mendeleev Commun., 1998, 165; (b) C. J. Marmion, T. Murphy, J. R. Docherty, K. B. Nolan, Chem Commun., 2000, 1153.
(a) V. G. Granik and N. B. Grigor’ev, Oksid azota (NO): novyi put’ k poisku lekarstv [Nitric Oxide (NO). New Route to Drug Design], Vuzovskaya kniga, Moscow, 2004, 360 pp. (in Russian); (b) A. R. Butler and R. Nicholson, Life, Death and Nitric Oxide, RS·C, Cambridge, 2003, 250p.
N. P. Konovalova, Tekhnologii zhivykh sistem [Technology of Living Systems], 2004, 1, 42 (in Russian); J. M. Fukuto, L. J. Ignarro, Acc. Chem. Res., 1997, 149.
I. V. Vystorop, K. A. Lyssenko, R. G. Kostyanovsky, Mendeleev Commun., 2002, 85.
I. V. Vystorop, K. A. Lyssenko, V. N. Voznesensky, V. P. Lodygina, R. G. Kostyanovsky, Mendeleev Commun., 2002, 193.
I. V. Vystorop, Z. G. Aliev, N. Yu. Andreeva, L. O. Atovmyan, B. S. Fedorov, Izv. Akad. Nauk, Ser. Khim., 2000, 180 [Russ. Chem. Bull., Int. Ed., 2000, 49, 182].
O. A. Luk’yanov, P. B. Gordeev, Izv. Akad. Nauk, Ser. Khim., 1998, 691 [Russ. Chem. Bull. (Engl. Transl.), 1998, 47, 669].
I. V. Vystorop, N. P. Konovalova, T. E. Sashenkova, B. S. Fedorov, Tez. dokl. IX Nauchnoi shkoly-konf. po organicheskoi khimii [Abstrs. of Papers, IX Scientific School-Conf. on Organic Chemistry] (December 11–15, 2006, Moscow), Moscow, 2006, p. 114 (in Russian).
G. I. Shchukin, I. A. Grigor’ev, L. B. Volodarskii, Khim. Geterotsikl. Soedin., 1990, 478 [Chem. Heterocycl. Compd. (Engl. Transl.), 1990, 26, 409].
C. Altona, M. Sundaralingam, J. Am. Chem. Soc., 1972, 94, 8205; C. Mathe, C. Perigand, Eur. J. Org. Chem., 2008, 1489.
I. V. Vystorop, A. Rauk, C. Jaime, I. Dinares and R. G. Kostyanovsky, Khim. Geterotsikl. Soedin., 1995, 1479 [Chem. Heterocycl. Compd. (Engl. Transl.),1995, 31, 1280].
A. Skancke, L. Vilkov, Acta Chem. Scand., 1988, 42A, 717.
L. Norskov-Lauritsen, H.-B. Burgi, P. Hofmann, H. R. Schmidt, Helv. Chim. Acta, 1985, 68, 76.
L. Bauer, O. Exner, Angew. Chem., Int. Ed., 1974, 13, 376.
R. S. Cahn, C. K. Ingold, V. Prelog, Angew. Chem., Int. Ed., 1966, 5, 385.
S. A. Glover, A. Rauk, J. Org. Chem., 1999, 64, 2340.
A. Alexakis, A. Tomassini, C. Chouillet, S. Roland, P. Man-geney, G. Bernardinelli, Angew. Chem., Int. Ed., 2000, 39, 4093.
R. M. Beesley, C. K. Ingold, J. F. Thorpe, J. Chem. Soc., 1915, 107, 1080; T. Ohwada, H. Hirao, A. Ogawa, J. Org. Chem., 2004, 69, 7486.
(a) O. L. Belaya, L. M. Baider, Z. V. Kuropteva, Byull. Eksp. Biol. Meditsiny, 2006, 142, 403 [Bull. Exp. Biol. Medicine (Engl. Transl.), 2006, 142]; (b) S. Archer, FASEB J., 1993, 7, 349.
V. N. Varfolomeev, N. P. Konovalova, B. S. Fedorov, T. E. Sashenkova, S. V. Blokhina, I. V. Vystorop, Tez. dokl. V natsional’noi nauchno-prakticheskoi konferentsii s mezh-dunarodnym uchastiem “Aktivnye formy kisloroda, oksid azota, antioksidanty i zdorov’e cheloveka” [Abstrs. of Papers, V All-Russian Scientific Practical Conference with International Participation “Active Forms of Oxygen, Nitric Oxide, Antioxidants, and Human Health”] (September 18–22, 2007, Smolensk), Smolensk, 2007, p. 14 (in Russian).
N. P. Konovalova, S. A. Goncharova, L. M. Volkova, T. A. Rajewskaya, L. T. Eremenko, A. M. Korolev, Nitric Oxide: Biology and Chemistry, 2003, 8, 59.
K. G. Cunningham, G. T. Newbold, F. S. Spring, J. Stark, J. Chem. Soc., 1949, 2091.
G. M. Sheldrick, SHELXTL v. 5.10, Structure Determination Software Suit, Bruker AXS, Madison, Wisconsin, USA.
G. N. Bogdanov, V. N. Varfolomeev, V. M. Pavlova, N. M. Emanuel’, Dokl. Akad. Nauk SSSR, 1976, 226, 207 [Dokl. Chem. (Engl. Transl.), 1976, 226].
Eksperimental’naya otsenka protivoopukholevykh preparatov v SSSR i SShA [Experimental Evaluation of Antitumor Drugs in the USSR and USA], Eds Z. P. Sofina, A. B. Syrkin (USSR), A. Goldin, A. Klein (USA), Meditsina, Moscow, 1980, 296 pp. (in Russian).
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 1, pp. 127–134, January, 2010.
Rights and permissions
About this article
Cite this article
Vystorop, I.V., Konovalova, N.P., Nelyubina, Y.V. et al. Cyclic hydroxamic acids derived from α-amino acids 1. Regioselective synthesis, structure, NO-donor and antimetastatic activities of spirobicyclic hydroxamic acids derived from glycine and DL-alanine. Russ Chem Bull 59, 127–135 (2010). https://doi.org/10.1007/s11172-010-0055-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11172-010-0055-x